Try
Praxis Precision Medicines Inc. Common Stock
PRAXUnited States
24 filed reports · 288 financial concepts · 1 earnings calls · 1 media appearances
Filed reports
24 reports · Sep 2020 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 18 | 2,318 | Sep 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 6 | 2,014 | Dec 2020 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 289 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 168 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 19, 2026 | 604 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 197 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 120 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 2, 2025 | 125 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 230 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 6, 2024 | 111 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 13, 2024 | 105 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 13, 2024 | 109 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 5, 2024 | 300 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 7, 2023 | 103 | Open |
Financial data
288 concepts · 4,332 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial279 concepts · 4,175 facts · Jun 2019 to Jul 2026
- Allocated share based compensation expense35 · Sep 2019 to Jun 2026
- Cash and cash equivalents at carrying value35 · Sep 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents35 · Sep 2019 to Jun 2026
- General and administrative expense (US GAAP)35 · Sep 2019 to Jun 2026
- Net income loss35 · Sep 2019 to Jun 2026
- Nonoperating income expense35 · Sep 2019 to Jun 2026
- Operating expenses (US GAAP)35 · Sep 2019 to Jun 2026
- Operating income loss35 · Sep 2019 to Jun 2026
- Research and development expense35 · Sep 2019 to Jun 2026
- Stockholders equity (US GAAP)35 · Sep 2019 to Jun 2026
- Depreciation34 · Dec 2019 to Jun 2026
- Increase decrease in accounts payable34 · Dec 2019 to Jun 2026
- Increase decrease in accrued liabilities34 · Dec 2019 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets34 · Dec 2019 to Jun 2026
- Net cash provided by used in financing activities34 · Dec 2019 to Jun 2026
- Net cash provided by used in investing activities34 · Dec 2019 to Jun 2026
- Net cash provided by used in operating activities34 · Dec 2019 to Jun 2026
- Other operating activities cash flow statement34 · Dec 2019 to Jun 2026
- Restricted cash34 · Dec 2019 to Jun 2026
- Share based compensation34 · Dec 2019 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value33 · Sep 2019 to Jun 2026
- Operating lease right of use asset amortization expense33 · Dec 2019 to Jun 2026
- Accounts payable current32 · Dec 2019 to Jun 2026
- Accretion amortization of discounts and premiums investments32 · Mar 2020 to Jun 2026
Segment9 concepts · 157 facts · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)65 · Dec 2023 to Jun 2026
- Allocated share based compensation expense13 · Dec 2023 to Jun 2026
- Depreciation13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other labor related expenses13 · Dec 2023 to Jun 2026
- Segment reporting other item amount13 · Dec 2023 to Jun 2026
- Revenue11 · Dec 2023 to Dec 2025
- Interest income operating9 · Dec 2023 to Sep 2025
- Other operating income expense net7 · Dec 2023 to Jun 2026
Segments
157 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 157 facts
- Reportable157 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary137 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary181 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes21 claims from 1 reports · Dec 2025
- Risk factors162 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
1 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances1 · Feb 2024
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.